Azacitidine Injection shortage
Azacitidine Injection is currently listed in shortage by the FDA. The FDA lists 9 affected products. The reported reason: Other; Demand increase for the drug; Discontinuation of the manufacture of the drug. This page was last refreshed from FDA data on Sep 21, 2026.
Azacitidine injection is in a shortage that has lasted over a year, with the 100 mg/4 mL strength currently having no available source. Other strengths are still listed by several manufacturers not reporting a shortage, including Sandoz, NorthStar Rx, Dr. Reddy's, and Apotex.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Azacitidine Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 17, 2026Currently in shortage9 of 9 products affected.
-
Sep 15, 2026FDA refreshed this shortage record4 products updated.
-
Sep 3, 2026FDA refreshed this shortage record1 product updated.
-
Aug 27, 2026FDA refreshed this shortage record1 product updated.
-
Aug 5, 2026FDA refreshed this shortage record1 product updated.
-
Jun 8, 2026FDA refreshed this shortage record1 product updated.
-
Dec 22, 2020More presentations reported2 more products added to the shortage.
-
Dec 21, 2020More presentations reported1 more product added to the shortage.
-
Dec 18, 2020First reported to the FDA6 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Accord Healthcare Inc. 📞 866-941-7875, option 2 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Azacitidine, Injection, 100 mg (NDC 16729-306-10) | — | Available | — | — |
Manufacturer: Armas Pharmaceuticals Inc 📞 732-637-1971 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Azacitidine, Injection, 100 mg (NDC 72485-201-01) | — | Limited Availability | Estimated recovery: TBD | Other |
Manufacturer: Bristol Myers Squibb Co. 📞 1-888-423-5436 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Vidaza, Injection, 100 mg (NDC 59572-102-01) | — | Available | — | — |
Manufacturer: Dr. Reddy's Laboratories, Inc. 📞 866-732-3952 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Azacitidine, Injection, 100 mg (NDC 43598-305-62) | — | Available | Available to existing customers | — |
Manufacturer: Eugia US LLC 📞 888-238-7880 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) | — | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
Manufacturer: Fresenius Kabi USA, LLC 📞 1-888-386-1300 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) | — | Unavailable | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
Manufacturer: Hikma Pharmaceuticals USA, Inc. 📞 1-800-631-2174 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) | — | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | — |
Manufacturer: Meitheal Pharmaceuticals, Inc. 📞 844-824-8426 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30) | — | Available | — | — |
Manufacturer: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Azacitidine, Injection, 100 mg (NDC 68001-313-56) | — | Unavailable | Estimated recovery: TBD | Other |
These rows are manufacturer reports to the FDA for Azacitidine Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Azacitidine Injection? options further down this page.
Why is Azacitidine Injection in shortage?
So here's what's going on with azacitidine right now. A few different manufacturers are involved, and the situation varies by company. Teva's 100 mg vials are currently unavailable, with no firm recovery date shared yet. Eugia's 100 mg/4 mL vials are on backorder due to more patients needing this medication than they can currently supply — again, no set return date. Armas Pharmaceuticals has only a limited supply of their 100 mg vials available, also with no confirmed recovery timeline. The manufacturer of the 100 mg/30 mL presentation has permanently stopped making that specific package size.
On a brighter note, a few versions are still moving. Dr. Reddy's 100 mg vials are available to their existing customers, and Bristol Myers Squibb's branded version, Vidaza (100 mg), is currently available. Meitheal Pharmaceuticals' 100 mg/30 mL is also listed as available. It's worth knowing that additional manufacturing lots are scheduled to help meet the overall demand as supply is released.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Azacitidine Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Azacitidine Injection?
Azacitidine injection is currently on the FDA drug-shortage list. This is an injectable cancer medicine, so it is usually given to you by a healthcare team rather than something you fill yourself — but I want you to understand where supply stands.
Not every strength is affected the same way. The 100 mg vial (including 100 mg and 100 mg/30 mL forms) still has an available source from more than one manufacturer, though some suppliers list it as available to existing customers only. The 100 mg/4 mL strength currently has no available source and is on backorder, with recovery listed as to-be-determined. One maker has also chosen to discontinue its 100 mg/30 mL product, so that particular version may not return. Overall, 6 of 9 manufacturers on this record still report supply. Reported reasons include increased demand and one company's decision to stop making its version.
Here is what I suggest:
- Do not stop, skip, or change your treatment on your own — your care team manages the timing and dose.
- Ask your pharmacy or clinic to order the 100 mg vial form, which still has supply; they can check wholesalers and other makers.
- Several other companies still list the same medicine, so your pharmacy may be able to source it, though it may not be in local stock right away.
- If your exact form can't be found, ask your prescriber about a clinician-chosen option.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually make these calls. This is national, manufacturer-reported data and may not match local stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Azacitidine Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Azacitidine Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | Sandoz Inc | 00781-3491-94 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | NorthStar RxLLC | 16714-0927-01 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | Dr. Reddy's Laboratories Inc. | 43598-0465-62 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | Apotex Corp | 60505-6271-01 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | BluePoint Laboratories | 68001-0527-54 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | BluePoint Laboratories. | 68001-0620-54 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | Somerset Therapeutics LLC | 70069-0857-01 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | Amneal Pharmaceuticals LLC | 70121-1237-01 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | 71288-0153-95 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | Civica, Inc. | 72572-0020-01 |
| Azacitidine | AZACITIDINE 100 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous | Pilnova Pharma Inc | 83774-0102-01 |
Alternative dosage forms of Azacitidine
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 26 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Azacitidine 100 mg | Hikma | 1 vial | — | AP | FDA listed |
| Azacitidine 100 mg | Sandoz | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | NorthStar | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | Accord | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | Camber | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | Dr. | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | Dr. | 1 injection | — | AP | FDA listed |
| Azacitidine Azacitidine 100 mg | Dr. | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg/50mL | Panacea | 1 vial | — | AP | FDA listed |
| Azacitidine 100 mg/4mL | Eugia | 1 vial | — | AP | FDA listed |
| Azacitidine 100 mg | Reliance | 1 vial | — | AP | FDA listed |
| Vidaza 100 mg | Celgene | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | Apotex | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg/30mL | Fresenius | 1 vial | — | AP | FDA listed |
| Azacitidine 100 mg | BluePoint | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | BluePoint | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | BluePoint | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | MSN | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | Somerset | 1 vial | — | AP | FDA listed |
| Azacitidine 100 mg | Amneal | 1 injection | — | — | FDA listed |
| Azacitidine 100 mg | Meitheal | 1 vial | — | AP | FDA listed |
| Azacitidine 100 mg | Meitheal | 1 vial | — | AP | FDA listed |
| Azacitidine 100 mg | Armas | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | Civica, | 1 injection | — | AP | FDA listed |
| Azacitidine 100 mg | Dr. | 1 vial | — | AP | FDA listed |
| Azacitidine 100 mg | Pilnova | 1 injection | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Azacitidine Injection — that fall in the same broad treatment class (antineoplastic - antimetabolites) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other oncology shortages
Azacitidine Injection shortage FAQs
Is Azacitidine Injection in shortage?
Why is Azacitidine Injection in shortage?
Which products are affected?
When will Azacitidine Injection be available again?
Can I still get Azacitidine somewhere?
What should I do if I take Azacitidine Injection?
Still have a question about the Azacitidine Injection shortage?
Ask a pharmacist about this shortage →View Azacitidine Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.